rs121918501
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000141.5(FGFR2):āc.868T>Gā(p.Trp290Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W290C) has been classified as Pathogenic.
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFR2 | NM_000141.5 | c.868T>G | p.Trp290Gly | missense_variant | 7/18 | ENST00000358487.10 | NP_000132.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.868T>G | p.Trp290Gly | missense_variant | 7/18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000457416.7 | c.868T>G | p.Trp290Gly | missense_variant | 7/18 | 1 | ENSP00000410294.2 | |||
FGFR2 | ENST00000369056.5 | c.868T>G | p.Trp290Gly | missense_variant | 6/17 | 1 | ENSP00000358052.1 | |||
FGFR2 | ENST00000369058.7 | c.868T>G | p.Trp290Gly | missense_variant | 7/17 | 1 | ENSP00000358054.3 | |||
FGFR2 | ENST00000613048.4 | c.601T>G | p.Trp201Gly | missense_variant | 6/17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000369059.5 | c.523T>G | p.Trp175Gly | missense_variant | 5/16 | 5 | ENSP00000358055.1 | |||
FGFR2 | ENST00000360144.7 | c.601T>G | p.Trp201Gly | missense_variant | 6/17 | 2 | ENSP00000353262.3 | |||
FGFR2 | ENST00000478859.5 | c.184T>G | p.Trp62Gly | missense_variant | 6/17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000369061.8 | c.749-4731T>G | intron_variant | 1 | ENSP00000358057.4 | |||||
FGFR2 | ENST00000604236.5 | n.523T>G | non_coding_transcript_exon_variant | 5/17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Crouzon syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Sep 17, 2016 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 1995 | - - |
FGFR2-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 18, 2024 | The FGFR2 c.868T>G variant is predicted to result in the amino acid substitution p.Trp290Gly. This variant has been reported in individuals with Crouzon or Pfeiffer sydrome (Park et al. 1995. PubMed ID: 8528214; Wenger et al. 2017. PubMed ID: 27228464; Machado et al. 2017. PubMed ID: 28815901; Bukowska-Olech et al. 2022. PubMed ID: 35591945; Lajeunie et al. 2006. PubMed ID: 16418739). Alternate missense substitutions at the same amino acid position (p.Trp290Cys, p.Trp290Arg, p.Trp290Ser, and p.Trp290Leu) have also been reported in individuals affected with craniosynostosis, Pfeiffer or Crouzon syndrome (Wenger et al. 2017. PubMed ID: 27228464; Nazzaro et al. 2004. PubMed ID: 15565658, Oldridge et al. 1995. PubMed ID: 7655462; Human Gene Mutation Database, http://www.hgmd.cf.ac.uk/ac/index.php). The c.868T>G (p.Trp290Gly) variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at